Autoantibody-associated movement disorders

Neuropediatrics

Volumn 44, Issue 6, 2013, Pages 336-345

  Mohammad, Shekeeb S ^a,b   Ramanathan, Sudarshini ^a   Brilot, Fabienne ^a   Dale, Russell C ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

autoantibodies; autoimmune; dopamine; encephalitis; movement disorders; NMDAR

Indexed keywords

AUTOANTIBODY; GLYCINE RECEPTOR; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AGITATION; AKINESIA; AUTOIMMUNE DISEASE; BASAL GANGLION; BRADYKINESIA; CHOREA MINOR; CHOREOATHETOSIS; DISEASE DURATION; DYSTONIA; ENCEPHALOMYELITIS; HUMAN; IMMUNOTHERAPY; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; MYOCLONUS; OROFACIAL DYSKINESIA; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SEIZURE; SOMNOLENCE; STEREOTYPY; TREMOR;

AUTOANTIBODIES; HUMANS; MOVEMENT DISORDERS;

EID: 84888335242     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0033-1358603     Document Type: Review

References (84)

1. Blumkin L., Pranzatelli M. R. Acquired ataxias, infectious and para-infectious. Handb Clin Neurol: 2012; 103 137 146
2. Gorman M. P. Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome. Curr Opin Pediatr: 2010; 22 6 745 750
3. Lancaster E., Dalmau J. Neuronal autoantigens pathogenesis, associated disorders and antibody testing. Nat Rev Neurol: 2012; 8 7 380 390
4. Panzer J., Dalmau J. Movement disorders in paraneoplastic and autoimmune disease. Curr Opin Neurol: 2011; 24 4 346 353
5. Hartley L. M., Ng S. Y., Dale R. C., Church A. J., Martinez A., de Sousa C. Immune mediated chorea encephalopathy syndrome in childhood. Dev Med Child Neurol: 2002; 44 4 273 277 (Pubitemid 34406517)
6. Dale R. C., Church A. J., Surtees R. A., et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain: 2004; 127 Pt 1 21 33 (Pubitemid 38055343)
7. Sébire G., Devictor D., Huault G., Aicardi J., Landrieu P., Tardieu M. Coma associated with intense bursts of abnormal movements and long-lasting cognitive disturbances: an acute encephalopathy of obscure origin. J Pediatr: 1992; 121 6 845 851
8. Dalmau J., Tüzün E., Wu H. Y., et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol: 2007; 61 1 25 36 (Pubitemid 46214241)
9. Titulaer M. J., McCracken L., Gabilondo I., et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol: 2013; 12 2 157 165
10. Dalmau J., Gleichman A. J., Hughes E. G., et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol: 2008; 7 12 1091 1098
11. Hughes E. G., Peng X., Gleichman A. J., et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci: 2010; 30 17 5866 5875
12. Armangue T., Titulaer M. J., Málaga I., et al. Spanish Anti-N-methyl-D-Aspartate Receptor (NMDAR) Encephalitis Work Group. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr: 2013; 162 4 850, e2
13. Florance N. R., Davis R. L., Lam C., et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol: 2009; 66 1 11 18
14. Irani S. R., Bera K., Waters P., et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain: 2010; 133 Pt 6 1655 1667
15. Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M. R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol: 2011; 10 1 63 74
16. Rubio-Agustí I., Dalmau J., Sevilla T., Burgal M., Beltrán E., Bataller L. Isolated hemidystonia associated with NMDA receptor antibodies. Mov Disord: 2011; 26 2 351 352
17. Baizabal-Carvallo J. F., Stocco A., Muscal E., Jankovic J. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord: 2013; 28 4 543 547
18. Hacohen Y., Wright S., Waters P., et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry: 2013; 84 7 748 755
19. Armangue T., Petit-Pedrol M., Dalmau J. Autoimmune encephalitis in children. J Child Neurol: 2012; 27 11 1460 1469
20. Davies G., Irani S. R., Coltart C., et al. Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med: 2010; 38 2 679 682
21. Dale R. C., Irani S. R., Brilot F., et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol: 2009; 66 5 704 709
22. Gable M. S., Gavali S., Radner A., et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis: 2009; 28 12 1421 1429
23. Kleinig T. J., Thompson P. D., Matar W., et al. The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord: 2008; 23 9 1256 1261
24. Sansing L. H., Tüzün E., Ko M. W., Baccon J., Lynch D. R., Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol: 2007; 3 5 291 296 (Pubitemid 46745476)
25. Vitaliani R., Mason W., Ances B., Zwerdling T., Jiang Z., Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol: 2005; 58 4 594 604 (Pubitemid 41377223)
26. Lebas A., Husson B., Didelot A., Honnorat J., Tardieu M. Expanding spectrum of encephalitis with NMDA receptor antibodies in young children. J Child Neurol: 2010; 25 6 742 745
27. Poloni C., Korff C. M., Ricotti V., et al. Severe childhood encephalopathy with dyskinesia and prolonged cognitive disturbances: evidence for anti-N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol: 2010; 52 5 e78 e82
28. Uchino A., Iizuka T., Urano Y., et al. Pseudo-piano playing motions and nocturnal hypoventilation in anti-NMDA receptor encephalitis: response to prompt tumor removal and immunotherapy. Intern Med: 2011; 50 6 627 630
29. Schimmel M., Bien C. G., Vincent A., Schenk W., Penzien J. Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia. Arch Dis Child: 2009; 94 4 314 316
30. Ramanathan S., Wong C. H., Fung V. S. Long duration between presentation of probable anti-N-methyl-D-aspartate receptor encephalitis and either clinical relapse or positive serum autoantibodies. J Clin Neurosci: 2013; 20 9 1322 1323
31. Consoli A., Ronen K., An-Gourfinkel I., et al. Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: case report. Child Adolesc Psychiatry Ment Health: 2011; 5 1 15
32. Baizabal-Carvallo J. F., Jankovic J. Movement disorders in autoimmune diseases. Mov Disord: 2012; 27 8 935 946
33. Stamelou M., Plazzi G., Lugaresi E., Edwards M. J., Bhatia K. P. The distinct movement disorder in anti-NMDA receptor encephalitis may be related to Status Dissociatus: a hypothesis. Mov Disord: 2012; 27 11 1360 1363
34. Chapman M. R., Vause H. E. Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry: 2011; 168 3 245 251
35. Maat P., de Graaff E., van Beveren N. M., et al. Psychiatric phenomena as initial manifestation of encephalitis by anti-NMDAR antibodies. Acta Neuropsychiatr: 2013; 25 3 128 136
36. Lopez-Alberola R., Georgiou M., Sfakianakis G. N., Singer C., Papapetropoulos S. Contemporary Encephalitis Lethargica: phenotype, laboratory findings and treatment outcomes. J Neurol: 2009; 256 3 396 404
37. Vilensky J. A., Foley P., Gilman S. Children and encephalitis lethargica: a historical review. Pediatr Neurol: 2007; 37 2 79 84 (Pubitemid 47187654)
38. Dale R. C., Merheb V., Pillai S., et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain: 2012; 135 Pt 11 3453 3468
39. Hall A. J. The lumleian lectures [abridged] on encephalitis lethargica (epidemic encephalitis). Lancet: 1923; 201 5198 731 740
40. Beattie G. C., Glaser C. A., Sheriff H., et al. Encephalitis with thalamic and basal ganglia abnormalities: etiologies, neuroimaging, and potential role of respiratory viruses. Clin Infect Dis: 2013; 56 6 825 832
41. Rail D., Scholtz C., Swash M. Post-encephalitic Parkinsonism: current experience. J Neurol Neurosurg Psychiatry: 1981; 44 8 670 676 (Pubitemid 11028113)
42. Blunt S. B., Lane R. J., Turjanski N., Perkin G. D. Clinical features and management of two cases of encephalitis lethargica. Mov Disord: 1997; 12 3 354 359 (Pubitemid 27216134)
43. The memorandum on encephalitis lethargica. Lancet: 1924; 203 5258 1163
44. Smith M. T., Lester-Smith D., Zurynski Y., Noonan S., Carapetis J. R., Elliott E. J. Persistence of acute rheumatic fever in a tertiary children's hospital. J Paediatr Child Health: 2011; 47 4 198 203
45. Cardoso F., Eduardo C., Silva A. P., Mota C. C. Chorea in fifty consecutive patients with rheumatic fever. Mov Disord: 1997; 12 5 701 703 (Pubitemid 27406264)
46. Klawans H. L., Brandabur M. M. Chorea in childhood. Pediatr Ann: 1993; 22 1 41 46, 49-50
47. Nausieda P. A., Grossman B. J., Koller W. C., Weiner W. J., Klawans H. L. Sydenham chorea: an update. Neurology: 1980; 30 3 331 334 (Pubitemid 10133776)
48. Teixeira A. L. Jr, Maia D. P., Cardoso F. [The initial testing and the discrimination property of the UFMG Sydenham's Chorea Rating Scale (USCRS)]. Arq Neuropsiquiatr: 2005; 63 3B 825 827 (Pubitemid 41494506)
49. Teixeira A. L. Jr, Maia D. P., Cardoso F. UFMG Sydenham's chorea rating scale (USCRS): reliability and consistency. Mov Disord: 2005; 20 5 585 591 (Pubitemid 40862256)
50. de Teixeira A. L., Cardoso F., Maia D. P., et al. Frequency and significance of vocalizations in Sydenham's chorea. Parkinsonism Relat Disord: 2009; 15 1 62 63
51. Mercadante M. T., Campos M. C., Marques-Dias M. J., Miguel E. C., Leckman J. Vocal tics in Sydenham's chorea. J Am Acad Child Adolesc Psychiatry: 1997; 36 3 305 306
52. El Otmani H., Moutaouakil F., Fadel H., Slassi I. Chorea paralytica: a videotape case with rapid recovery and good long-term outcome. Acta Neurol Belg: 2013
53. Cardoso F. Sydenham's Chorea. Curr Treat Options Neurol: 2008; 10 3 230 235
54. Giedd J. N., Rapoport J. L., Kruesi M. J., et al. Sydenham's chorea: magnetic resonance imaging of the basal ganglia. Neurology: 1995; 45 12 2199 2202 (Pubitemid 27100248)
55. Barsottini O. G., Ferraz H. B., Seviliano M. M., Barbieri A. Brain SPECT imaging in Sydenham's chorea. Braz J Med Biol Res: 2002; 35 4 431 436 (Pubitemid 34467332)
56. Walker K., Brink A., Lawrenson J., Mathiassen W., Wilmshurst J. M. Treatment of sydenham chorea with intravenous immunoglobulin. J Child Neurol: 2012; 27 2 147 155
57. Kirvan C. A., Swedo S. E., Heuser J. S., Cunningham M. W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med: 2003; 9 7 914 920 (Pubitemid 36889935)
58. Dale R. C., Candler P. M., Church A. J., Wait R., Pocock J. M., Giovannoni G. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol: 2006; 172 1-2 187 197 (Pubitemid 43277505)
59. Brimberg L., Benhar I., Mascaro-Blanco A., et al. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology: 2012; 37 9 2076 2087
60. Fusco C., Ucchino V., Frattini D., Pisani F., Della Giustina E. Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham's chorea. Eur J Paediatr Neurol: 2012; 16 4 373 378
61. Garvey M. A., Snider L. A., Leitman S. F., Werden R., Swedo S. E. Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol: 2005; 20 5 424 429 (Pubitemid 40873048)
62. Carapetis J. R., Currie B. J. Rheumatic chorea in northern Australia: a clinical and epidemiological study. Arch Dis Child: 1999; 80 4 353 358 (Pubitemid 29164760)
63. Teixeira A. L., Cardoso F., Maia D. P., Cunningham M. C. Sydenham's chorea may be a risk factor for drug induced parkinsonism. J Neurol Neurosurg Psychiatry: 2003; 74 9 1350 1351 (Pubitemid 37152281)
64. Cardoso F. Sydenham's chorea. Handb Clin Neurol: 2011; 100 221 229
65. Cardoso F., Vargas A. P., Oliveira L. D., Guerra A. A., Amaral S. V. Persistent Sydenham's chorea. Mov Disord: 1999; 14 5 805 807 (Pubitemid 29509623)
66. Korn-Lubetzki I., Brand A., Steiner I. Recurrence of Sydenham chorea: implications for pathogenesis. Arch Neurol: 2004; 61 8 1261 1264 (Pubitemid 39062681)
67. Aron A. M., Freeman J. M., Carter S. The Natural History of Sydenham's Chorea. Review of the Literature and Long-Term Evaluation with Emphasis on Cardiac Sequelae. Am J Med: 1965; 38 83 95
68. Gimeno H., Barry S., Lin J. P., Gordon A. Functional impact of Sydenham's Chorea: A Case Report. (e-pub ahead of print) Tremor Other Hyperkinet Mov (NY): 2013
69. Swedo S. E., Leckman J. F., Rose N. R. From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome). Pediatr Therapeut: 2012; 2 113
70. Singer H. S., Gilbert D. L., Wolf D. S., Mink J. W., Kurlan R. Moving from PANDAS to CANS. J Pediatr: 2012; 160 5 725 731
71. Singer H. S., Hong J. J., Yoon D. Y., Williams P. N. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology: 2005; 65 11 1701 1707
72. Church A. J., Dale R. C., Giovannoni G. Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders? Arch Dis Child: 2004; 89 7 611 614
73. Dale R. C., Heyman I., Surtees R. A., et al. Dyskinesias and associated psychiatric disorders following streptococcal infections. Arch Dis Child: 2004; 89 7 604 610
74. Martino D., Defazio G., Giovannoni G. The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder. J Psychosom Res: 2009; 67 6 547 557
75. Stern W. M., Howard R., Chalmers R. M., et al. Glycine receptor antibody mediated Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM): a rare but treatable neurological syndrome. (e-pub ahead of print). Pract Neurol: 2013
76. Hutchinson M., Waters P., McHugh J., et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology: 2008; 71 16 1291 1292
77. Damásio J., Leite M. I., Coutinho E., et al. Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies. JAMA Neurol: 2013; 70 4 498 501
78. Meinck H. M., Thompson P. D. Stiff man syndrome and related conditions. Mov Disord: 2002; 17 5 853 866 (Pubitemid 36040990)
79. Turner M. R., Irani S. R., Leite M. I., Nithi K., Vincent A., Ansorge O. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology: 2011; 77 5 439 443
80. Saidha S., Elamin M., Mullins G., Chaila E., Tormey V. J., Hennessy M. J. Treatment of progressive encephalomyelitis with rigidity and myoclonic jerks with rituximab: a case report. Eur J Neurol: 2008; 15 5 e33 (Pubitemid 351499185)
81. Clerinx K., Breban T., Schrooten M., et al. Progressive encephalomyelitis with rigidity and myoclonus: resolution after thymectomy. Neurology: 2011; 76 3 303 304
82. Suleiman J., Brilot F., Lang B., Vincent A., Dale R. C. Autoimmune epilepsy in children: case series and proposed guidelines for identification. Epilepsia: 2013; 54 6 1036 1045
83. Dale R. C., Brilot F., Fagan E., Earl J. Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation. Dev Med Child Neurol: 2009; 51 4 317 323
84. Sinclair A. J., Wienholt L., Tantsis E., Brilot F., Dale R. C. Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology. Dev Med Child Neurol: 2013; 55 1 71 75